New center to study bleeding disorders and clot formation
Researchers at Washington University School of Medicine have received a $9 million grant to investigate blood-clotting disorders. From heart attacks and strokes to uncontrolled bleeding, clotting disorders cause more deaths each year in the United States than all types of cancer combined.
 |
| Strands of a protein called von Willebrand Factor (orange) play a key role in blood clotting. Secreted by cells lining the blood vessels, the strands capture platelets and initiate the formation of blood clots |
“Blood clots in veins and arteries remain one of the great killers,” says principal investigator J. Evan Sadler, MD, PhD, professor of medicine and chief of the Division of Hematology. “The goal of this grant is to shorten the time between a new discovery in blood clotting or bleeding disorders and the application of that knowledge to help patients.”
Washington University is one of only five universities across the country receiving funding from the National Heart, Lung, and Blood Institute (NHLBI) to support a new Translational Research Center in Thrombotic and Hemostatic Disorders.
READ MORE
No comments:
Post a Comment